192 related articles for article (PubMed ID: 20176038)
1. Circulating endothelial cells as biomarkers in clinical oncology.
Mancuso P; Bertolini F
Microvasc Res; 2010 May; 79(3):224-8. PubMed ID: 20176038
[TBL] [Abstract][Full Text] [Related]
2. Circulating endothelial cells and circulating endothelial progenitors.
Mancuso P; Calleri A; Bertolini F
Recent Results Cancer Res; 2012; 195():163-70. PubMed ID: 22527503
[TBL] [Abstract][Full Text] [Related]
3. [Circulating endothelial cells: biomarkers for monitoring activity of antiangiogenic therapy].
Farace F; Bidart JM
Bull Cancer; 2007 Jul; 94 Spec No():S254-9. PubMed ID: 17846012
[TBL] [Abstract][Full Text] [Related]
4. Biomarkers for angiogenesis and antiangiogenic drugs in clinical oncology.
Bertolini F
Breast; 2009 Oct; 18 Suppl 3():S48-50. PubMed ID: 19914542
[TBL] [Abstract][Full Text] [Related]
5. The multiple personality disorder phenotype(s) of circulating endothelial cells in cancer.
Bertolini F; Mancuso P; Braidotti P; Shaked Y; Kerbel RS
Biochim Biophys Acta; 2009 Aug; 1796(1):27-32. PubMed ID: 19406208
[TBL] [Abstract][Full Text] [Related]
6. Circulating endothelial cells as biomarkers of prostate cancer.
Georgiou HD; Namdarian B; Corcoran NM; Costello AJ; Hovens CM
Nat Clin Pract Urol; 2008 Aug; 5(8):445-54. PubMed ID: 18682720
[TBL] [Abstract][Full Text] [Related]
7. The multifaceted circulating endothelial cell in cancer: towards marker and target identification.
Bertolini F; Shaked Y; Mancuso P; Kerbel RS
Nat Rev Cancer; 2006 Nov; 6(11):835-45. PubMed ID: 17036040
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy and the tumor microenvironment: the contribution of circulating endothelial cells.
Bertolini F
Cancer Metastasis Rev; 2008 Mar; 27(1):95-101. PubMed ID: 18066648
[TBL] [Abstract][Full Text] [Related]
9. Molecular and cellular biomarkers for angiogenesis in clinical oncology.
Bertolini F; Mancuso P; Shaked Y; Kerbel RS
Drug Discov Today; 2007 Oct; 12(19-20):806-12. PubMed ID: 17933680
[TBL] [Abstract][Full Text] [Related]
10. Clinical value of circulating endothelial cell detection in oncology.
Kraan J; Sleijfer S; Foekens JA; Gratama JW
Drug Discov Today; 2012 Jul; 17(13-14):710-7. PubMed ID: 22306349
[TBL] [Abstract][Full Text] [Related]
11. Flow cytometric detection of circulating endothelial cells and endothelial progenitor cells in healthy subjects.
Mariucci S; Rovati B; Bencardino K; Manzoni M; Danova M
Int J Lab Hematol; 2010 Feb; 32(1 Pt 1):e40-8. PubMed ID: 20088999
[TBL] [Abstract][Full Text] [Related]
12. Genetic heterogeneity of the vasculogenic phenotype parallels angiogenesis; Implications for cellular surrogate marker analysis of antiangiogenesis.
Shaked Y; Bertolini F; Man S; Rogers MS; Cervi D; Foutz T; Rawn K; Voskas D; Dumont DJ; Ben-David Y; Lawler J; Henkin J; Huber J; Hicklin DJ; D'Amato RJ; Kerbel RS
Cancer Cell; 2005 Jan; 7(1):101-11. PubMed ID: 15652753
[TBL] [Abstract][Full Text] [Related]
13. Global gene expression profiling of circulating endothelial cells in patients with metastatic carcinomas.
Smirnov DA; Foulk BW; Doyle GV; Connelly MC; Terstappen LW; O'Hara SM
Cancer Res; 2006 Mar; 66(6):2918-22. PubMed ID: 16540638
[TBL] [Abstract][Full Text] [Related]
14. Biologic markers of angiogenesis: circulating endothelial cells in patients with advanced malignancies treated on phase I protocol with metronomic chemotherapy and celecoxib.
Twardowski PW; Smith-Powell L; Carroll M; VanBalgooy J; Ruel C; Frankel P; Synold TW
Cancer Invest; 2008 Feb; 26(1):53-9. PubMed ID: 18181046
[TBL] [Abstract][Full Text] [Related]
15. Circulating endothelial cells and progenitors: potential biomarkers of renal cell carcinoma.
Namdarian B; Tan KV; Fankhauser MJ; Nguyen TT; Corcoran NM; Costello AJ; Hovens CM
BJU Int; 2010 Oct; 106(7):1081-7. PubMed ID: 20201835
[TBL] [Abstract][Full Text] [Related]
16. Safety, tolerability and biological effects of long-term metronomic administration of non-cytotoxic anti-angiogenic agents.
Noberasco C; Spitaleri G; Mancuso P; Zorzino L; Radice D; Milani A; Rocca A; Bertolini F; Sandri MT; Curigliano G; de Pas T; Jemos C; Omodeo Salè E; Boselli S; de Braud F
Oncology; 2009; 77(6):358-65. PubMed ID: 20068365
[TBL] [Abstract][Full Text] [Related]
17. Circulating endothelial cells and endothelial progenitors as surrogate biomarkers in vascular dysfunction.
Wu H; Chen H; Hu PC
Clin Lab; 2007; 53(5-6):285-95. PubMed ID: 17605403
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of circulating VEGFR2+ bone marrow-derived progenitor cells in patients with advanced cancer.
Massard C; Borget I; Le Deley MC; Taylor M; Gomez-Roca C; Soria JC; Farace F
Eur J Cancer; 2012 Jun; 48(9):1354-62. PubMed ID: 22370181
[TBL] [Abstract][Full Text] [Related]
19. Flow cytometric assessment of monocyte activation markers and circulating endothelial cells in patients with localized or metastatic breast cancer.
Goodale D; Phay C; Brown W; Gray-Statchuk L; Furlong P; Lock M; Chin-Yee I; Keeney M; Allan AL
Cytometry B Clin Cytom; 2009 Mar; 76(2):107-17. PubMed ID: 18727054
[TBL] [Abstract][Full Text] [Related]
20. Tumor vascularity in prostate cancer: an update on circulating endothelial cells and platelets as noninvasive biomarkers.
Reeves F; Sapre N; Corcoran N; Hovens C
Biomark Med; 2013 Dec; 7(6):879-91. PubMed ID: 24266820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
